Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Exxon Mobil ...

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Federal Workers Told to Inform on Colleagues Trying to Evade D.E.I. Crackdown Justice Department orders a halt to civil rights work. Budget nominee hints at work requirements for Medicaid. Local ...

People take pictures on an overpass with a display of stock information in front of buildings in the Lujiazui financial district in Shanghai, China August 6, 2024. REUTERS/Nicoco Chan/File photo ...

An exhibit at the Chicago Cultural Center is coming under fire. It includes a large puppet titled, "US-Israel War Machine." A brush fire erupted amid powerful winds Wednesday afternoon in the ...

Birthright citizenship -- which has been in place for decades -- means anyone born in the U.S. is a citizen, regardless of their parents' immigration status. SF and CA join lawsuit challenging ...